Universitat de ValènciaUniversitat Politècnica de ValènciaInteruniversity Research Institute for Molecular Recognition and Technological Development Logo del portal

Pragmatic, multicentre, randomized, controlled clinical trial in patients with Sepsis to evaluate the safety and efficacy of personalized PK/PD dosing versus standard Linezolid dosing
Acronym

SePkLin

Reference code

ICI21/00043

Description

Number of researchers 29

Total amount: 273.504 €

 

 

 

Non-UV principal researchers

Anxo Fernández Ferreiro

Start date
2022 January
End date
2025 December
Funding agencies:

Instituto de Salud Carlos III 

Partners:

Complejo Hospitalario Universitario de Santiago (CHUS)

Project type
  • EU - NextGenerationEU